Uroxatral and Diplopia - a phase IV clinical study of FDA data

Summary:

Diplopia is reported as a side effect among people who take Uroxatral (alfuzosin hydrochloride), especially for people who are male, 50-59 old, also take Ativan, and have Metastases to bone.

The phase IV clinical study analyzes which people have Diplopia when taking Uroxatral. It is created by eHealthMe based on reports of 3,182 people who have side effects when taking Uroxatral from the FDA, and is updated regularly.

What is Uroxatral?

Uroxatral has active ingredients of alfuzosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 3,461 Uroxatral users. Check the latest studies of Uroxatral.

What is Diplopia?

Diplopia (double vision) is found to be associated with 1,434 drugs and 1,892 conditions by eHealthMe. Check the latest studies of Diplopia.

On Jul, 10, 2026

3,182 people reported to have side effects when taking Uroxatral.
Among them, 17 people (0.53%) have Diplopia.

Among these 17 people:

What is the gender of people who have Diplopia when taking Uroxatral? *

female: 5.88 %
male: 94.12 %

What is the age of people who have Diplopia when taking Uroxatral? *

What are other drugs people take besides Uroxatral? *

What are other side effects people have besides Diplopia? *

Infection: 12 people, 70.59%
Herpes Virus Infection: 12 people, 70.59%
Fatigue (feeling of tiredness): 12 people, 70.59%
Febrile Neutropenia (fever with reduced white blood cells): 12 people, 70.59%
Fibula Fracture: 12 people, 70.59%
Flatulence (flatus expelled through the anus): 12 people, 70.59%
Gastritis (inflammation of stomach): 12 people, 70.59%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 12 people, 70.59%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 70.59%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 12 people, 70.59%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 12 people, 70.59%
Multiple Myeloma (cancer of the plasma cells): 8 people, 47.06%
Prostatic Disorder: 1 person, 5.88%
Parkinson's Disease: 1 person, 5.88%
Blood Testosterone Decreased: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Uroxatral and have Diplopia?

- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Uroxatral:

Uroxatral (3,461 reports)

Diplopia treatments and more:

Diplopia (32,465 reports)

Browse all side effects of Uroxatral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diplopia:

Diplopia (1,434 drugs)

Browse all the conditions that are associated with Diplopia:

Diplopia (1,892 conditions)

Related publications that referenced our studies

Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on alfuzosin hydrochloride (the active ingredients of Uroxatral) and Uroxatral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.